Siddhesh Joshi (Editor)

Jeffrey Karp

Updated on
Edit
Like
Comment
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit
Residence
  
United States

Education
  
University of Toronto

Name
  
Jeffrey Karp

Nationality
  
Canada


Jeffrey Karp NEWS The Karp Lab

Fields
  
Bioinspired medical problem solver, Tissue adhesives, Biomedical engineering, Mesenchymal stem cell therapy

Institutions
  
Harvard Medical School, Massachusetts Institute of Technology

Alma mater
  
McGill University, University of Toronto, Massachusetts Institute of Technology

Doctoral advisor
  
John Davies & Molly Shoichet

Academic advisor
  
Robert S. Langer

Mit news at noon jeffrey karp


Jeff Karp is a Canadian–born biomedical engineer. He is an Associate Professor of Medicine at Harvard Medical School, Brigham and Women's Hospital, and the principal faculty at the Harvard Stem Cell Institute and Affiliate Faculty at the Massachusetts Institute of Technology through the Harvard–MIT Division of Health Sciences and Technology. He is also an affiliate faculty at the Broad Institute.

Contents

Jeffrey Karp Champions in Health Care Jeffrey Karp innovator Boston

--> Karp's TEDMED Talk:


Jeffrey Karp httpsuploadwikimediaorgwikipediacommonsthu

--> Karp's Commencement Address:


Jeffrey Karp Meet the Editorial Board of Nanotechnology Jeff Karp

Karp has co-founded four medical companies, including Skintifique, which develops products for those with skin ailments or damaged/sensitive skin, Gecko Biomedical which develops hydrophobic light-activated adhesives (a type of surgical glue intended to augment or replace sutures), Alivio Therapeutics, which develops inflammation targeting and inflammation responsive materials for treating inflammatory diseases, and Frequency Therapeutics, which focuses on medical treatment for chronic hearing loss. Karp's companies collectively have raised >$80,000,000 and employ >60 people. In 2008 MIT's Technology Review listed him as one of the top innovators in the world under the age of 35 (TR35).

Jeffrey Karp researchfacultybrighamandwomensorgProfilePhotos

Education

Jeffrey Karp The Karp Lab

Jeff was born and raised in Peterborough, Ontario, graduating from Crestwood Secondary School. He graduated from McGill University in 1999 with a degree in chemical engineering. At McGill he was elected to the McGill Senate to represent over 2000 students, he was also a nominated member of the McGill Admissions Committee, the Advisory Committee to Select a new dean of Engineering, and the Student Affairs Senate Sub-Committee. While at McGill he also co-founded the McGill Engineering Code of Ethics "The Blueprint".

Jeffrey Karp TEDMED Speaker Jeff Karp

He received a Ph.D. in Chemical and Biomedical Engineering from the University of Toronto in 2004. While at the University of Toronto, he was head TA for the Faculty of Engineering, an active member of the Engineering Teaching Committee, and a board member of the Toronto chapter for the Canadian Biomaterials Society. He also actively volunteered on the oncology ward at the Hospital for Sick Children, and worked part-time for MadScience, a hands-on teaching program to spark the imagination and curiosity of elementary students.

Jeffrey Karp Turbocharging medical translation MIT News

From 2004 until 2007, Karp was an NSERC postdoctoral fellow in Robert Langer's laboratory at MIT.

Personal

Karp resides in Brookline, Massachusetts with his wife, two children, and his two King Charles spaniels.

Research

His research has led to several products on the market, and a number that are under clinical development. His most noticeable work includes bioinspired tissue adhesives to augment or replace sutures and staples, engineered stem cell homing, cell surface sensors, a needle that automatically stops when it gets to the right location, and inflammation responsive drug release.

Recognition

Karp has published more than 100 peer-reviewed papers (with 13,000 citations) and book chapters and has given over 250 national and international invited lectures and has >100 issued or pending patents. Several technologies that he has invented are currently being translated into medical products to improve the quality of life of suffering patients. Dr. Karp's work has been recognized by CNN, NPR Science Fridays, Boston Globe, ABC News, MSNBC, Fox News, CBC Quirks and Quarks, CanadaAM, BBC, LA Times, Forbes, National Geographic, Popular Science, the Washington Post, the New York Post, and by Wired Magazine.

To date, 18 trainees from his laboratory have secured faculty positions at institutions throughout the world.

Among other honors, Karp was elected as a new fellow in the American Institute for Medical and Biological Engineering's (AIMBE) College of Fellows. The College of Fellows is composed of about 1,000 (top 2%) of the country’s most outstanding biomedical and biological engineers in academia, industry, and government. Karp also received the 2011 Young Investigator award from the Society for Biomaterials, and Technology Review listed him in 2008 as one of the top innovators under the age of 35 (TR35).

His laboratory has been funded by multiple companies, foundations and governmental funding agencies including the Bill and Melinda Gates Foundation, NFL, Johnson & Johnson, Phillips, Sanofi, UCB, NIH, DOD, US Army, Kenneth Rainin Foundation, Helmsley Trust, JDRF, Rheumatology Research Foundation, Coulter Foundation, Prostate Cancer Foundation, Brain Science Foundation, American Heart Association, Deshpande Foundation, Institute for Pediatric Innovation, Boston Children’s Hospital, Brigham and Women’s Hospital, the Government of India and the Government of Korea. Dr. Karp also won an internal Shark Tank award judged by Kevin O’Leary.

Karp is a popular mentor in the MIT and Harvard community. He was selected as the Outstanding Faculty Undergraduate Mentor at MIT in 2008 and in 2010 the Harvard-MIT division HST granted him the McMahon Mentoring award as top mentor.

In 2011, the Boston Business Journal profiled him as a Champion in Health Care Innovation.

In 2012, two postdocs from his lab received the prestigious TR35 including Weian Zhao, Bryan Laulicht

In 2013, Karp and his collaborator Dr. Bohdan Pomahac were honored with the Innovative Product of the Year Award from the Institution of Chemical Engineers (IChemE) for their research on worm-inspired microneedle tissue adhesives

In 2014, Karp successfully pitched a 50K microbiome project at the Brigham and Women's Hospital Shark Tank event that was hosted live in Boston by Kevin O'Leary.

In 2014, Maria Nunes Pereira, a graduate student co-advised with Lino Ferreira received the prestigious TR35

In 2014, Karp presented a talk at TEDMED that shared unexpected insights into the field of bio-inspiration, the art and science of adapting medical tools, treatments, and technologies from solutions found in nature.

In 2015 Karp was recognized by the Boston Business Journal's top 40 under 40, and received the Kenneth Rainin Foundation's Breakthrough Award.

In 2016, Karp received a Breakthrough award from the Kenneth Rainin Foundation.

References

Jeffrey Karp Wikipedia